Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia
Objective This study evaluated the clinical efficacy of myometrial and endometrial microwave ablation (MEWA) for treating adenomyosis in patients with anemia.Methods This retrospective study enrolled 64 patients with adenomyosis who had anemia treated with either MEWA (MEWA group) or myometrial micr...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | International Journal of Hyperthermia |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/02656736.2022.2131001 |
| _version_ | 1797990730034053120 |
|---|---|
| author | Zuolin Li Xiaolian Li Min Lin Sihua Qiu Liangqin Wang Liping Lai Xuefen Luo Zunyu Mo Gang Dong Guorong Lyu Shuiping Li |
| author_facet | Zuolin Li Xiaolian Li Min Lin Sihua Qiu Liangqin Wang Liping Lai Xuefen Luo Zunyu Mo Gang Dong Guorong Lyu Shuiping Li |
| author_sort | Zuolin Li |
| collection | DOAJ |
| description | Objective This study evaluated the clinical efficacy of myometrial and endometrial microwave ablation (MEWA) for treating adenomyosis in patients with anemia.Methods This retrospective study enrolled 64 patients with adenomyosis who had anemia treated with either MEWA (MEWA group) or myometrial microwave ablation (MMWA group) between May 2019 and May 2021. The uterine volumes, uterine-volume reduction rates, hemoglobin (Hb) levels, cancer antigen 125 (CA125) levels, dysmenorrhea visual analog scale (VAS) scores, uterine fibroblast symptoms and health-related quality of life (UFS-QOL) scores, menstrual flow scores (MFS) before and 3, 6, and 12 months post-treatment, and adverse events and complications in both groups were collected to assess clinical efficacy.Results No statistically significant preoperative differences were observed in any measured factors. Postoperatively, there was a significant reduction in uterine volume and CA125 level, an increase in Hb level, and improvement in the UFS-QOL, dysmenorrhea VAS score, and MFS. No differences were observed in postoperative uterine volume, CA125 level, overall response rate, and adverse event rate during the follow-up period until 12 months postoperatively. However, the MEWA group showed a better uterine-volume reduction rate 6 months postoperatively and improvement in Hb level, USF-QOL score, dysmenorrhea VAS score, and MFS postoperatively.Conclusion MEWA and MMWA demonstrated high clinical efficacy in treating adenomyosis and anemia. However, MEWA is a more effective therapy that successfully improves anemia, resulting in improved quality of life. |
| first_indexed | 2024-04-11T08:40:07Z |
| format | Article |
| id | doaj.art-ab8dd0d558e54c778df75bd9860019e2 |
| institution | Directory Open Access Journal |
| issn | 0265-6736 1464-5157 |
| language | English |
| last_indexed | 2024-04-11T08:40:07Z |
| publishDate | 2022-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | International Journal of Hyperthermia |
| spelling | doaj.art-ab8dd0d558e54c778df75bd9860019e22022-12-22T04:34:13ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572022-12-013911335134310.1080/02656736.2022.2131001Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemiaZuolin Li0Xiaolian Li1Min Lin2Sihua Qiu3Liangqin Wang4Liping Lai5Xuefen Luo6Zunyu Mo7Gang Dong8Guorong Lyu9Shuiping Li10Department of Ultrasound, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaDepartment of Ultrasound, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaDepartment of Ultrasound, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaDepartment of Ultrasound, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaDepartment of Ultrasound, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaDepartment of Ultrasound, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaDepartment of Ultrasound, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaDepartment of Ultrasound, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaDepartment of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaCollaborative Innovation Centre for Maternal and Infant Health Service Application Technology, Quanzhou Medical College, Quanzhou, ChinaDepartment of Ultrasound, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, ChinaObjective This study evaluated the clinical efficacy of myometrial and endometrial microwave ablation (MEWA) for treating adenomyosis in patients with anemia.Methods This retrospective study enrolled 64 patients with adenomyosis who had anemia treated with either MEWA (MEWA group) or myometrial microwave ablation (MMWA group) between May 2019 and May 2021. The uterine volumes, uterine-volume reduction rates, hemoglobin (Hb) levels, cancer antigen 125 (CA125) levels, dysmenorrhea visual analog scale (VAS) scores, uterine fibroblast symptoms and health-related quality of life (UFS-QOL) scores, menstrual flow scores (MFS) before and 3, 6, and 12 months post-treatment, and adverse events and complications in both groups were collected to assess clinical efficacy.Results No statistically significant preoperative differences were observed in any measured factors. Postoperatively, there was a significant reduction in uterine volume and CA125 level, an increase in Hb level, and improvement in the UFS-QOL, dysmenorrhea VAS score, and MFS. No differences were observed in postoperative uterine volume, CA125 level, overall response rate, and adverse event rate during the follow-up period until 12 months postoperatively. However, the MEWA group showed a better uterine-volume reduction rate 6 months postoperatively and improvement in Hb level, USF-QOL score, dysmenorrhea VAS score, and MFS postoperatively.Conclusion MEWA and MMWA demonstrated high clinical efficacy in treating adenomyosis and anemia. However, MEWA is a more effective therapy that successfully improves anemia, resulting in improved quality of life.https://www.tandfonline.com/doi/10.1080/02656736.2022.2131001Adenomyosisanemiamyometrial and endometrial microwave ablationmyometrial microwave ablationclinical efficacy |
| spellingShingle | Zuolin Li Xiaolian Li Min Lin Sihua Qiu Liangqin Wang Liping Lai Xuefen Luo Zunyu Mo Gang Dong Guorong Lyu Shuiping Li Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia International Journal of Hyperthermia Adenomyosis anemia myometrial and endometrial microwave ablation myometrial microwave ablation clinical efficacy |
| title | Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia |
| title_full | Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia |
| title_fullStr | Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia |
| title_full_unstemmed | Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia |
| title_short | Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia |
| title_sort | clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia |
| topic | Adenomyosis anemia myometrial and endometrial microwave ablation myometrial microwave ablation clinical efficacy |
| url | https://www.tandfonline.com/doi/10.1080/02656736.2022.2131001 |
| work_keys_str_mv | AT zuolinli clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia AT xiaolianli clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia AT minlin clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia AT sihuaqiu clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia AT liangqinwang clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia AT lipinglai clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia AT xuefenluo clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia AT zunyumo clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia AT gangdong clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia AT guoronglyu clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia AT shuipingli clinicalefficacyofmyometrialandendometrialmicrowaveablationinthetreatmentofpatientswithadenomyosiswhohadanemia |